We included 133 studies with 4243 ADRs reported in 197,675 neonates, infants, and children who received azithromycin. The safety of azithromycin as MDA in pediatrics was poorly monitored. The main ADRs were diarrhea and vomiting. In prospective non-MDA studies, the most common toxicity was gastrointestinal ADRs (938/1967; 47.7%). The most serious toxicities were cardiac (prolonged QT or irregul…
Azithromycin (AZM), sold under the name Zithromax, is classified as a macrolide. It has many benefits due to its immunomodulatory, anti-inflammatory, and antibacterial effects. This review aims to study different clinical and biochemisterial aspects and properties of this drug which has a priority based on literature published worldwide
Gonorrhea is the second most common sexually transmitted bacterial infection (STI) next to Chlamydia. Untreated cases could results in major complications like pelvic inflammatory disease (PID), ectopic pregnancy, infertility, miscarriage, fetal death and congenital infections. Gonorrhea has been treated with antibiotics for more than eight decades. However, the emergence and spread of antim…
Adverse events and laboratory abnormalities were monitored over 35 days after the commencement of treatment in 45 open studies conducted in Europe, South America, Africa and Asia. These studies were to assess the clinical efficacies of azithromycin and comparator antimicrobial agents in the treatment of paediatric acute bacterial infections.
This study was designed to evaluate the efficacy of a 3 day course of azithromycin in low to moderately severe community-acquired pneumonia
Although universal immuni-zation against Bordetella pertussis(whooping cough) infection has resulted in dramatic reductions in the incidence of pertussis, outbreaks continue to occur in countries with excellent vaccine coverage.
Despite increasing concerns over macrolide resistance and a higher incidence of Gram-negative pathogens, a standard 5-day course of oral azithromycin was clinically and bacteriologically equivalent to a 7-day course of oral levofloxacin in the treatment of patients with ABECB.
Dexan, pernahkah merasakan penglihatan mulai menurun atau berubah? Pneglihatan yang awalnya jernih menjadi berkabut? Atau, penglihatan malam Dexan menjadi berkurang? Pernah atau tidak, ini adalah kesempatan emas untuk Dexan mempelajari tentang kesehatan mata, gejala penyakit mata penyebabnya, pengobatannya hingga pencegahan yang bisa Dexan lakukan
Anda adalah pribadi yang Amazing dan itu tidak dapat dibantah. Walaupun mungkin Anda sendiri tidak menyadarinya. Diri Anda yang sekarang adalah hasil dari serangkaian persitiwa yang telah Anda lewati dan melalui proses panjang. Anda, sang pemeran utama dalam hidup sedang berjuang memberikan pertunjukan yang menakjubkan. Apa yang Anda perjuangkan saat ini menentukan akhir dari cerita hidup Anda.…